Tim Evans
Stock Analyst at Wells Fargo
(2.48)
# 2,151
Out of 4,818 analysts
23
Total ratings
72.73%
Success rate
4.35%
Average return
Main Sectors:
Stocks Rated by Tim Evans
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIO Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $249.66 | +12.15% | 2 | Feb 28, 2018 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $234.41 | +19.45% | 2 | Feb 28, 2018 | |
| MEDP Medpace Holdings | Maintains: Market Perform | $38 → $35 | $290.54 | -87.95% | 3 | Feb 28, 2018 | |
| ILMN Illumina | Upgrades: Outperform | n/a | $76.36 | - | 2 | Jan 2, 2018 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $105 → $112 | $217.28 | -48.45% | 4 | Oct 27, 2017 | |
| DGX Quest Diagnostics | Maintains: Market Perform | $88 → $86 | $173.78 | -50.51% | 2 | Oct 20, 2017 | |
| LH Labcorp Holdings | Reinstates: Outperform | $175 | $224.40 | -22.01% | 1 | Oct 12, 2017 | |
| TECH Bio-Techne | Initiates: Market Perform | n/a | $50.18 | - | 1 | Jul 13, 2017 | |
| DHR Danaher | Initiates: Market Perform | $90 | $196.31 | -54.15% | 1 | Jul 13, 2017 | |
| MTD Mettler-Toledo International | Upgrades: Outperform | n/a | $1,050.62 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $37.92 | - | 2 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $105.00 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.46 | - | 1 | May 3, 2017 |
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $249.66
Upside: +12.15%
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $234.41
Upside: +19.45%
Medpace Holdings
Feb 28, 2018
Maintains: Market Perform
Price Target: $38 → $35
Current: $290.54
Upside: -87.95%
Illumina
Jan 2, 2018
Upgrades: Outperform
Price Target: n/a
Current: $76.36
Upside: -
West Pharmaceutical Services
Oct 27, 2017
Maintains: Outperform
Price Target: $105 → $112
Current: $217.28
Upside: -48.45%
Quest Diagnostics
Oct 20, 2017
Maintains: Market Perform
Price Target: $88 → $86
Current: $173.78
Upside: -50.51%
Labcorp Holdings
Oct 12, 2017
Reinstates: Outperform
Price Target: $175
Current: $224.40
Upside: -22.01%
Bio-Techne
Jul 13, 2017
Initiates: Market Perform
Price Target: n/a
Current: $50.18
Upside: -
Danaher
Jul 13, 2017
Initiates: Market Perform
Price Target: $90
Current: $196.31
Upside: -54.15%
Mettler-Toledo International
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $1,050.62
Upside: -
Jul 13, 2017
Downgrades: Underperform
Price Target: n/a
Current: $37.92
Upside: -
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $105.00
Upside: -
May 3, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $1.46
Upside: -